These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5525569)

  • 1. [Tuberculosis and live with special reference to lesions due to antimycobacterial agents].
    Daddi G; Boccitto G; Storniello G; Salvati F
    Epatologia; 1970; 16(1):71-6. PubMed ID: 5525569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioisotope study of liver function in drug-induced toxico-allergic reactions in patients with ruberculosis].
    Vil'derman AM; Frenkel' VKh; Reznik SE; Tikhun MN
    Med Radiol (Mosk); 1967 Apr; 12(4):62-6. PubMed ID: 6052187
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and experimental studies of liver damages in tuberculosis, with special reference to liver damages caused by antitubercular agents and the autonomic nervous factor].
    Homma Y
    Iryo; 1969 Apr; 23(4):482-501. PubMed ID: 5804545
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of some liver function tests routinely performed in early detection of damage to liver parenchyma in patients with pulmonary tuberculosis].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1205-9. PubMed ID: 5139239
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H
    Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver function disorders in the course of continuous and intermittent treatment of patients with chronic pulmonary tuberculosis.
    Kucharska A
    Gruzlica; 1975 Dec; 43(12):1099-106. PubMed ID: 1193414
    [No Abstract]   [Full Text] [Related]  

  • 10. Are antitubercular drugs prescribed correctly and scientifically?
    Sahoo RC
    J Assoc Physicians India; 1994 Apr; 42(4):349-50. PubMed ID: 7860579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medication-induced hepatic lesions in patients with pulmonary tuberculosis].
    Gned'ko NI
    Voen Med Zh; 2002 May; 323(5):56-8. PubMed ID: 12073843
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of hepatotoxicity of antitubercular drugs in patients with pulmonary tuberculosis abusing alcohol].
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Gruzlica; 1969 Aug; 37(8):749-57. PubMed ID: 5352301
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic function monitoring during tuberculotherapy (author's transl)].
    Pageaux JF; Duperray B; Dubois M; Pacheco H; Pacheco Y; Brun J; Perrin-Fayolle M; Kofman J
    Therapie; 1979; 34(4):505-13. PubMed ID: 531782
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects and toxicity of ethionamide and prothionamide.
    Tala E; Tevola K
    Ann Clin Res; 1969 May; 1(1):32-5. PubMed ID: 5350768
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver damage of allergic origin during treatment with antitubercular agents].
    Kürti V; Novák O
    Cas Lek Cesk; 1968 Jun; 107(26):780-4. PubMed ID: 5661073
    [No Abstract]   [Full Text] [Related]  

  • 20. [Danger of liver damage in modern antitubercular treatment].
    Kozma D; Lapis K; Debreczeni L
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():479-81. PubMed ID: 6647279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.